Skip Navigation

Find a Doctor

Find a Researcher


Richard Ernest Chaisson, M.D.

Photo of Dr. Richard Ernest Chaisson, M.D.
  • Director, Center for Tuberculosis Research
  • Professor of Medicine


HIV/AIDS, Infectious Disease

Request an Appointment

Insurance Information


Request Appointment

Outside of Maryland

Request Appointment

International Patients

Request Appointment


The Johns Hopkins Hospital

Appointment Phone: 410-955-1725
600 N. Wolfe Street Carnegie 3 Baltimore, MD 21287 map
Phone: 410-955-1755 | Fax: 410-955-0740


Dr. Richard E. Chaisson is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in epidemiology and in international health, both in the Johns Hopkins Bloomberg School of Public Health. His area of clinical expertise is infectious diseases, particularly HIV/AIDS. 

Dr. Chaisson serves as the director of the Johns Hopkins University Center for Tuberculosis Research, the director and principal investigator of the Johns Hopkins Center for AIDS Research.

He received his B.S. and M.D. degrees from the University of Massachusetts. He was an intern, resident, fellow and assistant professor of medicine at the University of California, San Francisco, prior to moving to Johns Hopkins.

From 1988 to 1998 he was director of the Johns Hopkins AIDS Service, and he co-founded the Johns Hopkins HIV Clinic cohort, an observational study that has been the source of hundreds of scientific publications on the outcomes of HIV disease and its treatment.  He founded the Center for TB Research which is the leading academic center for basic, clinical, applied, and epidemiologic investigations in TB and its control.  

Dr. Chaisson has been recognized with numerous honors, including the Champions of TB Control Award from the U.S. Agency for International Development (USAID) in 2014 and the American Thoracic Society's World Lung Health Award in 2006. more


  • Director, Center for Tuberculosis Research
  • Director and Principal Investigator, Center for AIDS Research
  • Director, Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE)
  • Professor of Medicine

Departments / Divisions

Centers & Institutes



  • MD, Univ of Massachusetts Medical School-Nursing (1982)


  • University of California San Francisco School of Medicine / Internal Medicine (1985)


  • University of California San Francisco School of Medicine (1987)

Board Certifications

  • American Board of Internal Medicine / Internal Medicine (1985)

Research & Publications

Research Summary

Dr. Chaisson’s research focuses on tuberculosis and HIV infection, including global control, prevention, clinical trials and public health interventions. He leads research projects in South Africa, Malawi, Brazil and India, and serves as chair of the Tuberculosis Transformative Science Group of the AIDS Clinical Trials Group.

He serves as the principal investigator of numerous research grants and of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE).

Clinical Trial Keywords

Tuberculosis, Tuberculosis screening, HIV-infected pregnant women, HIV-infected Malawians, HIV-associated lung infections and complications

Selected Publications

Getahun H, Chaisson RE, Raviglione M. "Latent Mycobacterium tuberculosis Infection." N Engl J Med. 2015 Sep 17;373(12):1179-80. doi: 10.1056/NEJMc1508223. No abstract available.

Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium. "Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid." JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158.

Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD; Thibela TB Study Team. "A trial of mass isoniazid preventive therapy for tuberculosis control." N Engl J Med. 2014 Jan 23;370(4):301-10. doi: 10.1056/NEJMoa1214289.

Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE. "Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial." Lancet Infect Dis. 2013 Oct;13(10):852-8. doi: 10.1016/S1473-3099(13)70187-7. Epub 2013 Aug 16.

Dowdy DW, Golub JE, Chaisson RE, Saraceni V. "Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics." Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9557-62. doi: 10.1073/pnas.1203517109. Epub 2012 May 29.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. "Three months of rifapentine and isoniazid for latent tuberculosis infection." N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.

Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE. "New regimens to prevent tuberculosis in adults with HIV infection." N Engl J Med. 2011 Jul 7;365(1):11-20. doi: 10.1056/NEJMoa1005136.

Academic Affiliations & Courses

Courses and Syllabi

  • Epidemiologic Basis for Tuberculosis Control (340.612.01)
  • Epidemiologic Basis for Tuberculosis Control (340.612.81)

Activities & Honors


  • Champions of TB Control Award, U.S. Agency for International Development (USAID), 2014
  • Charles C. Shepard Science Award, Centers for Disease Control and Prevention, 2012
  • Dr. David Glasser Memorial Tuberculosis Control and Prevention Award, Maryland Department of Health and Mental Hygiene, 2008
  • World Lung Health Award, American Thoracic Society, 2006

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button